These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

868 related items for PubMed ID: 24384028

  • 1. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters.
    Tseng TC, Liu CJ, Yang WT, Chen CL, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1242-9. PubMed ID: 24384028
    [Abstract] [Full Text] [Related]

  • 2. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.
    Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.
    Hepatology; 2012 Jan; 55(1):68-76. PubMed ID: 21858846
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.
    Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, Chen DS, Kao JH.
    Gastroenterology; 2011 Aug; 141(2):517-25, 525.e1-2. PubMed ID: 21672542
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H, Lee JM, Seo JH, Kim HS, Ahn SH, Kim DY, Han KH, Chon CY, Park JY.
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [Abstract] [Full Text] [Related]

  • 6. Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.
    Tseng TC, Liu CJ, Chen CL, Wang CC, Su TH, Kuo SF, Chen PJ, Chen DS, Kao JH.
    J Infect Dis; 2012 Jan 01; 205(1):54-63. PubMed ID: 22095766
    [Abstract] [Full Text] [Related]

  • 7. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P.
    J Clin Virol; 2013 Oct 01; 58(2):401-7. PubMed ID: 24004660
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA.
    Hepatology; 2010 Jun 01; 51(6):1933-44. PubMed ID: 20512987
    [Abstract] [Full Text] [Related]

  • 11. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
    Tseng TC, Liu CJ, Chen CL, Yang HC, Su TH, Wang CC, Yang WT, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.
    J Infect Dis; 2013 Aug 15; 208(4):584-93. PubMed ID: 23656977
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.
    Fung J, Seto WK, Wong DK, Lai CL, Yuen MF.
    Liver Int; 2015 Mar 15; 35(3):854-9. PubMed ID: 24840542
    [Abstract] [Full Text] [Related]

  • 13. Distinct seromarkers predict different milestones of chronic hepatitis B progression.
    Liu J, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL, Hsiao CK, Chen CJ, REVEAL-HBV Study Group.
    Hepatology; 2014 Jul 15; 60(1):77-86. PubMed ID: 24700432
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK, Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, Agelopoulou OP, Syminelaki T, Papaioannou C, Nastos T, Karayiannis P.
    J Hepatol; 2011 Jul 15; 55(1):61-8. PubMed ID: 21145875
    [Abstract] [Full Text] [Related]

  • 15. Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.
    Kwak MS, Cho EJ, Jang ES, Lee JH, Yu SJ, Kim YJ, Yoon JH, Lee HS.
    Digestion; 2011 Jul 15; 84 Suppl 1():23-8. PubMed ID: 22156482
    [Abstract] [Full Text] [Related]

  • 16. Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation.
    Tseng TC, Liu CJ, Su TH, Yang HC, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.
    J Infect Dis; 2012 Nov 15; 206(10):1521-31. PubMed ID: 22966125
    [Abstract] [Full Text] [Related]

  • 17. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan 15; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 18. Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.
    Chen J, Wang Z, Zhou B, Wang Y, Hou J.
    Antivir Ther; 2012 Jan 15; 17(1):71-9. PubMed ID: 22267471
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.